Armand Blommaert

The CCK‐B Agonist, BC264, Increases Dopamine in the Nucleus Accumbens and Facilitates Motivation and Attention After lntraperitoneal Injection in Rats

Nathalie Ladurelle, G. Keller, Armand Blommaert et al. · European Journal of Neuroscience · 1997 · 44 citations

Cck‐b Agonist, Cholecystokinin Fragment Cck4, Neurotransmitter +30

Cholecystokinin peptidomimetics as selective CCK-B antagonists: Design, synthesis, and in vitro and in vivo biochemical properties

Armand Blommaert, Jian Hui Weng, Agnes Dorville et al. · Journal of Medicinal Chemistry · 1993 · 43 citations · Full text

Altmetric Attention Score, Pharmacotherapy, System Pharmacology +22

A selective CCKB receptor antagonist potentiates μ-, but not δ-opioid receptor-mediated antinociception in the formalin test

Florence Noble, Armand Blommaert, Marie‐Claude Fournié‐Zaluski et al. · European Journal of Pharmacology · 1995 · 43 citations

Molecular Pharmacology, Pain Disorders, Health Sciences +15

Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity

Armand Blommaert, Serge Turcaud, Christine Anne et al. · Bioorganic & Medicinal Chemistry · 2004 · 32 citations

Small Tripeptide Surrogates, Biochemistry, Medicine +6

Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCK_B antagonist PD‐134,308

Rafaël Maldonado, Olga Valverde, Bertrand Ducos et al. · British Journal of Pharmacology · 1995 · 28 citations · Full text